Our Recommendations
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) (2022)
- Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
New Publications
- Therapeutics and COVID-19 (Living Guideline, 10 November 2023) (2023)
- Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage (2023)
- Clinical management of COVID-19: Living guideline, 18 August 2023 (2023)
- Drugs to prevent COVID-19: living guideline (2023)
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
Filter
550
Featured
Recommendations
140
New Publications
3
Language
Document type
Guidelines
283
Fact sheets
90
Studies & Reports
55
Manuals
41
Infographics
22
Videos
14
Resource Platforms
13
Online Courses
13
Training Material
10
Situation Updates
5
Brochures
2
No document type
2
Countries / Regions
Russia
50
Brazil
44
Germany
29
Latin America and the Carribbean
27
Middle East and North Africa
22
Mozambique
21
West and Central Africa
21
Angola
21
Guinea-Bissau
16
East and Southern Africa
16
Africa
13
Global
11
Syria
10
Eastern Europe and Central Asia
10
Yemen
10
Spain
9
South Africa
7
Western and Central Europe
5
Eastern Europe
5
Ecuador
5
India
4
Western Pacific Region
3
France
3
Argentina
3
Vietnam
3
South Sudan
3
Ukraine
2
Kazakhstan
2
Nigeria
2
Philippines
2
Haiti
2
South–East Asia Region
2
Portugal
2
Sudan
2
Nepal
1
Switzerland
1
El Salvador
1
Turkey
1
Benin
1
Togo
1
China
1
Cameroon
1
Canada
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Burundi
1
Austria
1
Italy
1
Cambodia
1
Venezuela
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Djibouti
1
Central African Republic
1
Ethiopia
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
224
Clinical Guidelines
31
Pharmacy & Technologies
21
Women & Child Health
16
Capacity Building
9
Key Resources
4
Public Health
2
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health outcomes and the quality of life. H...
10 Janaury 2022 The following catalogue lists all the medical devices including personal protective equipment, medical equipment, medical consumables, single use devices and laboratory and test related devices.
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
Ce document d'orientation est destiné aux cliniciens qui s'occupent de patients atteints de COVID-19 à toutes les phases de leur maladie (c'est-à-dire du dépistage à la sortie de l'hôpital). Cette mise à jour a été étendue pour répondre aux besoins des cliniciens de première ligne et fa...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
22 July 2022. This document provides the case definitions for public health surveillance of COVID-19 in humans caused by SARS-COV-2 infection.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Poster, 4 Janaury 2022
